Stocksigma LogoStocksigma Logo

CRISIL Upgrades Tatva Chintan Pharma Chem's Credit Ratings

CRISIL Ratings upgraded Tatva Chintan Pharma Chem Limited鈥檚 credit ratings on 8th Sep'26 across Rs 245 crore total bank loan facilities

CRISIL Upgrades Tatva Chintan Pharma Chem's Credit Ratings

Tatva Chintan Pharma Chem Ltd 路 Others (Uncategorized) 路 08 Sept 2026, 10:47 pm

CRISIL Upgrades Tatva Chintan Pharma Chem's Credit Ratings CRISIL Ratings upgraded Tatva Chintan Pharma Chem Limited鈥檚 credit ratings on 8th Sep'26 across Rs 245 crore total bank loan facilities. Long-term bank facilities were upgraded to CRISIL A-/Stable from CRISIL BBB+/Stable, while short-term facilities were upgraded to CRISIL A2+ from CRISIL A2. The rated debt profile comprises Rs 220 crore in fund-based limits, Rs 10.5 crore in letter of credit and bank guarantees, alongside a Rs 14.5 crore proposed term loan. The upgrade reflects strengthened creditworthiness and improved financial risk metrics.

Original exchange filing (PDF)

More announcements from Tatva Chintan Pharma Chem Ltd

All Tatva Chintan Pharma Chem Ltd announcements